Quidel | 20398 | QuickVue® At-Home OTC COVID-19 Rapid Test Kit

Local Phone #
Toll Free Phone #
  • Shopping Cart(0)
  • My Account
Menu

Advanced search

Home > QuickVue® At-Home OTC COVID-19 Rapid Test Kit, 25 Tests

Quidel 20398 QuickVue® At-Home OTC COVID-19 Rapid Test Kit

Image Of QuickVue® At-Home OTC COVID-19 Rapid Test Kit

Image shown for reference purposes only. Actual product appearance may vary.

$25.50
Box of 2
20398

Quidel

New In stock Available Options:
Box of 2 $25.50
Kit of 25 $275.00

Add to Shopping Cart
or

Product Details

Quidel Brand Test Kits Supplies, Reorder Code 20398

Non-Returnable

  • The QuickVue At-Home OTC COVID-19 Test is intended for the qualitative detection of nucleocapsid proteins from SARS-CoV-2 from individuals with or without symptoms or other epidemiological reasons to suspect COVID-19 when tested twice over two or three days with at least 24 hours and no more than 36 hours between tests
  • This test is authorized for nonprescription home use with self-collected (unobserved) direct anterior nasal(NS) swab specimens from individuals aged 14 years and older or with adult-collected anterior NS samples from individuals aged 2 years or older
  • Positive results indicate the presence of virus-specific proteins, but clinical correlation with past medical history and other diagnostic information is necessary to determine infection status
  • Positive results do not rule out bacterial infection or co-infection with other viruses and the agent detected may not be the definite cause of disease. Individuals who test positive with the QuickVue At-Home OTC COVID-19 Test should self-isolate and seek follow-up care with their physician or healthcare provider as additional testing may be necessary
  • Negative results should be treated as presumptive, do not rule out SARS-CoV-2 infection and should not be used as the sole basis for treatment or patient management decisions, including infection control decisions
  • Negative results should be considered in the context of an individual’s recent exposures, history and the presence of clinical signs and symptoms consistent with COVID-19, and confirmed with a molecular assay, if necessary, for patient management
  • Individuals should provide all results obtained with this product to their healthcare provider for public health reporting
  • This product has been authorized only for the detection of proteins from SARS-CoV-2, not for any other viruses or pathogens
  • The test is intended to be read at 10 minutes; If the test is read before this or is read more than 5 minutes after the indicated read time, results may be inaccurate and the test should be repeated